{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:45:23Z","timestamp":1788432323413,"version":"build-2803163510"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.hoc.2024.05.012","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T07:49:26Z","timestamp":1722239366000},"page":"1087-1110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cutaneous T-cell Lymphoma"],"prefix":"10.1016","volume":"38","author":[{"given":"David M.","family":"Weiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.hoc.2024.05.012_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2024.05.012_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0889-8588(18)30052-2","article-title":"Epidemiology and clinical manifestations of cutaneous T-cell lymphoma","volume":"9","author":"Koh","year":"1995","journal-title":"Hematol Oncol Clin N Am"},{"issue":"1","key":"10.1016\/j.hoc.2024.05.012_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2024.05.012_bib4","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3390\/cancers12102921","article-title":"Epidemiology of cutaneous T-cell lymphomas: a systematic review and meta-analysis of 16,953 patients","volume":"12","author":"Dobos","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.hoc.2024.05.012_bib5","unstructured":"Alibert, J.L. Description des maladies de la peau: observ\u00e9es \u00e0 l'H\u00f4pital Saint-Louis, et exposition des meilleures m\u00e9thodes suivies pour leur traitement. Vol. 2. 1825: Wahlen."},{"key":"10.1016\/j.hoc.2024.05.012_bib6","first-page":"254","article-title":"Erythrodermie avec pr\u00e9sence de cellules monstrueuses dans le derme et le sang circulant","volume":"45","author":"S\u00e9zary","year":"1938","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"issue":"6","key":"10.1016\/j.hoc.2024.05.012_bib7","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaad.2012.04.043","article-title":"S\u00e9zary syndrome: a study of 176 patients at Mayo Clinic","volume":"67","author":"Kubica","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.hoc.2024.05.012_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"issue":"19","key":"10.1016\/j.hoc.2024.05.012_bib9","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Girardi","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2024.05.012_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/1346-8138.16288","article-title":"Pathogenesis of cutaneous T\u00a0cell lymphoma: Involvement of Staphylococcus aureus","volume":"49","author":"Fujii","year":"2022","journal-title":"J\u00a0Dermatol (Tokyo)"},{"issue":"20","key":"10.1016\/j.hoc.2024.05.012_bib11","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/jnci\/81.20.1560","article-title":"Mycosis fungoides in relation to environmental exposures and immune response: a case-control study","volume":"81","author":"Whittemore","year":"1989","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.hoc.2024.05.012_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archderm.1987.01660260066015","article-title":"A\u00a0case-control study of possible causative factors in mycosis fungoides","volume":"123","author":"Tuyp","year":"1987","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.hoc.2024.05.012_bib13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1182\/blood.V53.4.642.642","article-title":"Cutaneous T-cell lymphoma: neoplasm of T\u00a0cells with helper activity","volume":"53","author":"Berger","year":"1979","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2024.05.012_bib14","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T\u00a0cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.hoc.2024.05.012_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.hoc.2024.05.012_bib16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.hoc.2024.05.012_bib17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ajh.25577","article-title":"Mycosis fungoides and S\u00e9zary syndrome: 2019 update on diagnosis, risk-stratification, and management","volume":"94","author":"Hristov","year":"2019","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.hoc.2024.05.012_bib18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.clml.2023.05.001","article-title":"Characterizing outcomes in visceral cutaneous t-cell lymphoma: a single center retrospective study","volume":"23","author":"Zhuang","year":"2023","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"issue":"5","key":"10.1016\/j.hoc.2024.05.012_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/ddg.13514","article-title":"Folliculotropic mycosis fungoides","volume":"16","author":"Mitteldorf","year":"2018","journal-title":"JDDG J der Deutschen Dermatol Gesellschaft"},{"key":"10.1016\/j.hoc.2024.05.012_bib20","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1590\/abd1806-4841.20132336","article-title":"Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology","volume":"88","author":"Furlan","year":"2013","journal-title":"An Bras Dermatol"},{"issue":"12","key":"10.1016\/j.hoc.2024.05.012_bib21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/DAD.0000000000000207","article-title":"Mycosis fungoides: an updated review of clinicopathologic variants","volume":"36","author":"Ahn","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.hoc.2024.05.012_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.hoc.2018.08.003","article-title":"A\u00a0review of primary cutaneous CD30+ lymphoproliferative disorders","volume":"33","author":"Chen","year":"2019","journal-title":"Hematol\/Oncol Clin"},{"issue":"9","key":"10.1016\/j.hoc.2024.05.012_bib23","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2024.05.012_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T\u00a0cell lymphomas: A distinct clinicopathological entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.hoc.2024.05.012_bib25","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cup.12091","article-title":"Indolent course of cutaneous gamma-delta T-cell lymphoma","volume":"40","author":"Endly","year":"2013","journal-title":"J\u00a0Cutan Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2024.05.012_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ajco.13787","article-title":"The pathophysiology and current treatments for the subcutaneous panniculitis-like T\u00a0cell lymphoma: An updated review","volume":"19","author":"Lin","year":"2023","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.hoc.2024.05.012_bib27","first-page":"433","article-title":"Les parapsoriasis","volume":"3","author":"Brocq","year":"1902","journal-title":"Ann Dermatol Syphiligr"},{"issue":"5","key":"10.1016\/j.hoc.2024.05.012_bib28","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s13555-022-00716-y","article-title":"Parapsoriasis\u2014a diagnosis with an identity crisis: a narrative review","volume":"12","author":"Chairatchaneeboon","year":"2022","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.hoc.2024.05.012_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/00015550510030087","article-title":"A\u00a0retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides","volume":"85","author":"V\u00e4kev\u00e4","year":"2005","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.hoc.2024.05.012_bib30","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/jid.2012.13","article-title":"Molecular markers of early-stage mycosis fungoides","volume":"132","author":"Zhang","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.hoc.2024.05.012_bib31","series-title":"Handbook of practical immunohistochemistry: frequently asked questions","first-page":"833","article-title":"Cutaneous Lymphomas","author":"Junkins-Hopkins","year":"2022"},{"issue":"3","key":"10.1016\/j.hoc.2024.05.012_bib32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2017.05.015","article-title":"CD8+ mycosis fungoides: a low-grade lymphoproliferative disorder","volume":"77","author":"Martinez-Escala","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.hoc.2024.05.012_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/cup.13894","article-title":"A\u00a0review of CD30 expression in cutaneous neoplasms","volume":"48","author":"Kampa","year":"2021","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2024.05.012_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.det.2015.05.002","article-title":"Pathologic Diagnosis of Cutaneous Lymphomas","volume":"33","author":"Kempf","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.hoc.2024.05.012_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0303-6987.2006.00541.x","article-title":"On the diagnosis of erythrodermic cutaneous T-cell lymphoma","volume":"33","author":"Vonderheid","year":"2006","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2024.05.012_bib36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1468-3083.2004.00937.x","article-title":"Clinicopathological spectrum of mycosis fungoides","volume":"18","author":"Kazakov","year":"2004","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.hoc.2024.05.012_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archderm.138.2.191","article-title":"Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: A clinicopathologic and follow-up study of 51 patients","volume":"138","author":"Van Doorn","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.hoc.2024.05.012_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1684\/ejd.2020.3698","article-title":"Sensitivity and specificity of T-cell receptor PCR BIOMED-2 clonality analysis for the diagnosis of cutaneous T-cell lymphoma","volume":"30","author":"Moczko","year":"2020","journal-title":"Eur J Dermatol"},{"issue":"9","key":"10.1016\/j.hoc.2024.05.012_bib39","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/jclinpath-2018-205004","article-title":"Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma","volume":"71","author":"Rea","year":"2018","journal-title":"J\u00a0Clin Pathol"},{"issue":"308","key":"10.1016\/j.hoc.2024.05.012_bib40","doi-asserted-by":"crossref","first-page":"308ra158","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T\u00a0cells as the cell of origin in CTCL","volume":"7","author":"Kirsch","year":"2015","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.hoc.2024.05.012_bib41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/bjd.20432","article-title":"Diagnostic performance of high-throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma","volume":"185","author":"Zimmermann","year":"2021","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2024.05.012_bib42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1084\/jem.179.2.609","article-title":"Clonal populations of T\u00a0cells in normal elderly humans: the T\u00a0cell equivalent to\" benign monoclonal gammapathy\"","volume":"179","author":"Posnett","year":"1994","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.hoc.2024.05.012_bib43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0190-9622(08)80970-X","article-title":"T-cell receptor gene rearrangement analysis: cutaneous T\u00a0cell lymphoma, peripheral T\u00a0cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders","volume":"25","author":"Zelickson","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2024.05.012_bib44","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jaad.2007.06.004","article-title":"T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides","volume":"57","author":"Thurber","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2024.05.012_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/bjd.21053","article-title":"Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach","volume":"187","author":"Vermeer","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.hoc.2024.05.012_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2018.01.076","article-title":"Blood classification and blood response criteria in mycosis fungoides and S\u00e9zary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force","volume":"93","author":"Scarisbrick","year":"2018","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2024.05.012_bib47","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jid.2020.09.011","article-title":"Utility of TRBC1 expression in the diagnosis of peripheral blood involvement by cutaneous T-cell lymphoma","volume":"141","author":"Horna","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2024.05.012_bib48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaad.2010.08.037","article-title":"S\u00e9zary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)","volume":"64","author":"Olsen","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2024.05.012_bib49","first-page":"419","article-title":"Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC","volume":"140","author":"Olsen","year":"2022","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.hoc.2024.05.012_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11899-007-0035-x","article-title":"Adult T-cell leukemia\/lymphoma and HTLV-1","volume":"2","author":"Mahieux","year":"2007","journal-title":"Current Hematologic Malignancy Reports"},{"key":"10.1016\/j.hoc.2024.05.012_bib51","unstructured":"Primary Cutaneous Lymphomas. 2024, NCCN clinical practice guidelines in oncology."},{"issue":"1","key":"10.1016\/j.hoc.2024.05.012_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/1097-0142(19800101)45:1<137::AID-CNCR2820450124>3.0.CO;2-K","article-title":"Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides","volume":"45","author":"Scheffer","year":"1980","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.hoc.2024.05.012_bib53","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0046-8177(85)80177-5","article-title":"Histologic assessment of lymph nodes in mycosis fungoides\/Sezary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system","volume":"16","author":"Sausville","year":"1985","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.hoc.2024.05.012_bib54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/1097-0142(19930801)72:3<726::AID-CNCR2820720316>3.0.CO;2-P","article-title":"Prognostic implications of a bone marrow histopathologic classification system in mycosis fungoides and the S\u00e9zary syndrome","volume":"72","author":"Graham","year":"1993","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.hoc.2024.05.012_bib55","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1995.01690210033005","article-title":"Prognostic factors in erythrodermic mycosis fungoides and the S\u00e9zary syndrome","volume":"131","author":"Kim","year":"1995","journal-title":"Arch Dermatol"},{"issue":"31","key":"10.1016\/j.hoc.2024.05.012_bib56","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2024.05.012_bib57","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1309\/AJCPH2PHXFCX3BOX","article-title":"A\u00a0review of survival in mycosis fungoides","volume":"141","author":"Vollmer","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"18","key":"10.1016\/j.hoc.2024.05.012_bib58","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.hoc.2024.05.012_bib59","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T\u00a0cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.hoc.2024.05.012_bib60","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/exd.14211","article-title":"Molecular pathogenesis of cutaneous lymphoma\u2013Future directions","volume":"29","author":"Stadler","year":"2020","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2024.05.012_bib61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1203475417745825","article-title":"Distribution and clustering of cutaneous T-cell lymphoma (CTCL) cases in Canada during 1992 to 2010","volume":"22","author":"Ghazawi","year":"2018","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.hoc.2024.05.012_bib62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jaad.2006.09.016","article-title":"Cutaneous T-cell lymphoma in non-blood-related family members: Report of an additional case","volume":"56","author":"Lozano","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.hoc.2024.05.012_bib63","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaad.2003.12.052","article-title":"Familial mycosis fungoides: report of 6 kindreds and a study of the HLA system","volume":"52","author":"Hodak","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2024.05.012_bib64","first-page":"767","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"16","key":"10.1016\/j.hoc.2024.05.012_bib65","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/bloodadvances.2018022608","article-title":"Single-cell heterogeneity in S\u00e9zary syndrome","volume":"2","author":"Buus","year":"2018","journal-title":"Blood Advances"},{"issue":"8","key":"10.1016\/j.hoc.2024.05.012_bib66","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.3390\/cancers15082362","article-title":"Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma","volume":"15","author":"Kalliara","year":"2023","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.hoc.2024.05.012_bib67","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/ijd.15451","article-title":"Cell signaling in cutaneous T-cell lymphoma microenvironment: promising targets for molecular-specific treatment","volume":"60","author":"Rend\u00f3n-Serna","year":"2021","journal-title":"Int J Dermatol"},{"issue":"22","key":"10.1016\/j.hoc.2024.05.012_bib68","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.3390\/cells11223591","article-title":"Targeting the CD47-SIRP\u03b1 Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma","volume":"11","author":"Xiao","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.hoc.2024.05.012_bib69","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaad.2020.12.027","article-title":"The immunopathogenesis and immunotherapy of cutaneous T\u00a0cell lymphoma: Pathways and targets for immune restoration and tumor eradication","volume":"84","author":"Durgin","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.hoc.2024.05.012_bib70","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/ijd.14391","article-title":"Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients","volume":"58","author":"Jaque","year":"2019","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.hoc.2024.05.012_bib71","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1038\/bcj.2017.85","article-title":"Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions","volume":"7","author":"Van der Weyden","year":"2017","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.hoc.2024.05.012_bib72","first-page":"3077","article-title":"CD30-CD30 ligand interaction in primary cutaneous CD30+ T-cell lymphomas: a clue to the pathophysiology of clinical regression","volume":"94","author":"Mori","year":"1999","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"3","key":"10.1016\/j.hoc.2024.05.012_bib73","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2020.12.026","article-title":"The immunopathogenesis and immunotherapy of cutaneous T\u00a0cell lymphoma: Current and future approaches","volume":"84","author":"Weiner","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.hoc.2024.05.012_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7625926","article-title":"Mogamulizumab multimodality therapy with systemic retinoids, interferon, or extracorporeal photopheresis for advanced cutaneous t-cell lymphoma","volume":"2023","author":"Weiner","year":"2023","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.hoc.2024.05.012_bib75","doi-asserted-by":"crossref","first-page":"iv30","DOI":"10.1093\/annonc\/mdy133","article-title":"Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Willemze","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2024.05.012_bib76","doi-asserted-by":"crossref","first-page":"113343","DOI":"10.1016\/j.ejca.2023.113343","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome\u2013update 2023","volume":"195","author":"Latzka","year":"2023","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.hoc.2024.05.012_bib77","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3816\/CLM.2006.n.063","article-title":"High clinical response rate with multimodality immunomodulatory therapy for Sezary syndrome","volume":"7","author":"Richardson","year":"2006","journal-title":"Clinical Lymphoma and Myeloma"},{"issue":"9","key":"10.1016\/j.hoc.2024.05.012_bib78","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2024.05.012_bib79","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.critrevonc.2012.06.002","article-title":"Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma: a systematic review","volume":"85","author":"Schlaak","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"10.1016\/j.hoc.2024.05.012_bib80","doi-asserted-by":"crossref","first-page":"e15538","DOI":"10.1111\/dth.15538","article-title":"Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case","volume":"35","author":"Weiner","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.hoc.2024.05.012_bib81","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-030-55617-4_8","article-title":"Interleukin-31, a potent pruritus-inducing cytokine and its role in inflammatory disease and in the tumor microenvironment","volume":"1290","author":"Rook","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.hoc.2024.05.012_bib82","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2011.12.021","article-title":"Pruritus in cutaneous T-cell lymphoma: a review","volume":"67","author":"Ahern","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.hoc.2024.05.012_bib83","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.det.2015.05.013","article-title":"Practical management of CD30+ lymphoproliferative disorders","volume":"33","author":"Hughey","year":"2015","journal-title":"Dermatol Clin"},{"issue":"15","key":"10.1016\/j.hoc.2024.05.012_bib84","first-page":"4024","article-title":"USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.hoc.2024.05.012_bib85","series-title":"Skin Lymphoma: The Illustrated Guide","author":"Cerroni","year":"2020"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824000613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824000613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T16:24:03Z","timestamp":1725035043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858824000613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0889858824000613"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2024.05.012","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous T-cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2024.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}